triiodothyronine has been researched along with Local Neoplasm Recurrence in 13 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Regorafenib demonstrated encouraging results in recurrent glioblastoma patients." | 8.31 | Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study. ( Bruno, F; Caccese, M; Cavallin, F; Cerretti, G; Chioffi, F; Coppola, M; Della Puppa, A; Denaro, L; Desideri, I; Fiorentino, A; Livi, L; Lombardi, G; Maccari, M; Padovan, M; Pittaro, A; Rudà, R, 2023) |
| "Regorafenib demonstrated encouraging results in recurrent glioblastoma patients." | 4.31 | Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study. ( Bruno, F; Caccese, M; Cavallin, F; Cerretti, G; Chioffi, F; Coppola, M; Della Puppa, A; Denaro, L; Desideri, I; Fiorentino, A; Livi, L; Lombardi, G; Maccari, M; Padovan, M; Pittaro, A; Rudà, R, 2023) |
| "Thyroid function was measured by means of thyroid stimulating hormone (TSH), free thyroxine (FT4) and free triiodthyronine (FT3) in 43 patients who had nonthyroid head-neck carcinomas treated by radiotherapy or radiotherapy in combination with other modalities." | 3.80 | Hypothyroidism after radiotherapy of head and neck cancer. ( Bernát, L; Hrušák, D, 2014) |
| "Sixty-two metastases or recurrences of differentiated thyroid carcinomas were investigated using conventional histology and immunocytochemistry for thyroglobulin (TG), thyroxine (T4) and triiodothyronine (T3)." | 3.68 | Histology and immunocytochemistry of differentiated thyroid carcinomas do not predict radioiodine uptake: a clinicomorphological study of 62 recurrent or metastatic tumours. ( Bätge, B; Dralle, H; Padberg, B; Schröder, S; von Herbay, B, 1992) |
| "Serum 'free thyroxine' was measured as a thyroid function index (TFI) in 238 women with early breast cancer and 107 normal controls." | 3.66 | Thyroid function in early breast cancer. ( Bulbrook, RD; Hayward, JL; Millis, R; Russell, MJ; Thomas, BS, 1983) |
| "In patients with differentiated thyroid cancer (DTC), the stimulated serum thyroglobulin (Tg) level at radioiodine ablation is a known predictive factor of persistent disease." | 1.40 | Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden. ( Bardet, S; Blanchard, D; Ciappuccini, R; de Raucourt, D; Hardouin, J; Heutte, N; Quak, E; Rame, JP; Vaur, D, 2014) |
| "The non-surgical treatment of thyroid cancer is outlined." | 1.25 | The non-surgical treatment of thyroid cancer. ( Halnan, KE, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Meirovitz, A | 1 |
| Nisman, B | 2 |
| Allweis, TM | 2 |
| Carmon, E | 2 |
| Kadouri, L | 2 |
| Maly, B | 2 |
| Maimon, O | 2 |
| Peretz, T | 2 |
| Liu, Y | 1 |
| Huang, Y | 1 |
| Mo, G | 1 |
| Zhou, T | 1 |
| Hou, Q | 1 |
| Shi, C | 1 |
| Yu, J | 1 |
| Lv, Y | 1 |
| Caccese, M | 1 |
| Desideri, I | 1 |
| Padovan, M | 1 |
| Bruno, F | 1 |
| Cerretti, G | 1 |
| Fiorentino, A | 1 |
| Denaro, L | 1 |
| Chioffi, F | 1 |
| Della Puppa, A | 1 |
| Maccari, M | 1 |
| Cavallin, F | 1 |
| Coppola, M | 1 |
| Pittaro, A | 1 |
| Rudà, R | 1 |
| Livi, L | 1 |
| Lombardi, G | 1 |
| Meierovich, A | 1 |
| Bernát, L | 1 |
| Hrušák, D | 1 |
| Ciappuccini, R | 1 |
| Hardouin, J | 1 |
| Heutte, N | 1 |
| Vaur, D | 1 |
| Quak, E | 1 |
| Rame, JP | 1 |
| Blanchard, D | 1 |
| de Raucourt, D | 1 |
| Bardet, S | 1 |
| Thomas, BS | 1 |
| Bulbrook, RD | 1 |
| Russell, MJ | 1 |
| Hayward, JL | 1 |
| Millis, R | 1 |
| Pujol, P | 1 |
| Osman, A | 1 |
| Bringer, J | 1 |
| Jaffiol, C | 1 |
| Braga, M | 1 |
| Ringel, MD | 1 |
| Cooper, DS | 1 |
| Geissl, G | 1 |
| Heinze, G | 1 |
| Pickardt, CR | 1 |
| Halnan, KE | 1 |
| Bätge, B | 1 |
| Dralle, H | 1 |
| Padberg, B | 1 |
| von Herbay, B | 1 |
| Schröder, S | 1 |
| Gardner, B | 1 |
13 other studies available for triiodothyronine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Thyroid Hormones and Morphological Features of Primary Breast Cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Carcinoma in Situ; Cell Proliferation; Female; Hum | 2022 |
Combined prognostic value of preoperative serum thyrotrophin and thyroid hormone concentration in papillary thyroid cancer.
Topics: Humans; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Risk Factors; Thyroid Cancer, | 2022 |
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study.
Topics: Glioblastoma; Humans; Neoplasm Recurrence, Local; Retrospective Studies; Thyroid Function Tests; Thy | 2023 |
Thyroid Hormones, Silencing Mediator for Retinoid and Thyroid Receptors and Prognosis in Primary Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Disease-Free Survival; Female; | 2020 |
Hypothyroidism after radiotherapy of head and neck cancer.
Topics: Aged; Carcinoma; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Follow-Up Studies; | 2014 |
Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Rad | 2014 |
Thyroid function in early breast cancer.
Topics: Adult; Aged; Androsterone; Breast Neoplasms; Etiocholanolone; Female; Humans; Mastectomy; Middle Age | 1983 |
Prevention of thyroid neoplasm recurrence with Triac and levothyroxine.
Topics: Carcinoma; Drug Therapy, Combination; Humans; Neoplasm Recurrence, Local; Thyroid Neoplasms; Thyroxi | 1997 |
Sudden enlargement of local recurrent thyroid tumor after recombinant human TSH administration.
Topics: Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Hormone Replacement Therapy; Humans; Magnetic | 2001 |
[TSH state after thyroid hormone deprivation in athyrotic thyroid cancer patients (author's transl)].
Topics: Female; Humans; Hypothyroidism; Iodine; Iodine Radioisotopes; Male; Neoplasm Metastasis; Neoplasm Re | 1977 |
The non-surgical treatment of thyroid cancer.
Topics: Adenocarcinoma; Age Factors; Aged; Calcitonin; Carcinoma, Papillary; Cell Count; Cell Survival; Chil | 1975 |
Histology and immunocytochemistry of differentiated thyroid carcinomas do not predict radioiodine uptake: a clinicomorphological study of 62 recurrent or metastatic tumours.
Topics: Adenocarcinoma; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Neoplasm Recurrence, Local; Thyro | 1992 |
Current concepts in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Adult; Androgens; Breast Neoplasms; Castration; Estrogens; Female; Fluorouracil; Huma | 1972 |